DHA (Docosahexaenoic Acid) Not classified
No linked studies yet.
Wild Alaskan Fish Oil Peak EPA
Goals
$71.19 $0.59 per serving
Product analysis
Wild Alaskan Fish Oil Peak EPA supplies EPA and DHA that may support how the body handles blood fats. Its connection to everyday concentration is less certain than its heart-related purpose.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality20
The associated fish oil is identified as ethyl esters, while individual nutrient forms are not separately stated. Those disclosure gaps limit a clear comparison of ingredient quality.
Ingredient Transparency46
EPA and DHA amounts are stated separately, helping you compare the fats that matter for the product’s purpose. Several other amounts, individual forms and parts of the fat breakdown are missing.
Value For Money60
The combined EPA and DHA amount offers strong value, with EPA also comparing favorably on its own. DHA alone is relatively costly, so value depends on which fat you are seeking.
Customer Satisfaction91
Customer ratings are very positive across several thousand buyers. The substantial review base supports a clearer view of satisfaction without confirming health effects.
Product Focus70
The clearest fit is heart-related support through effects on blood-fat handling. Focus and inflammation-related benefits are less certain, especially for noticeable everyday changes.
- Format
Softgel - Container
- 120 Softgel(s)
- Per serving
- $0.59
- Customer rating
- 4.8 · 5,121 ratings
Goals
Impact
Highest effect
EPA (Eicosapentaenoic Acid) · 750 mg
EPA is linked mainly to triglyceride-related support, while DHA has more limited lipid and vascular evidence. Their separately declared amounts establish active content, unlike total fish-oil mass. Routine supplementation has not established prevention of major cardiovascular events, and prescription EPA findings in selected high-risk patients do not transfer to this product. The two fats do not imply an extra benefit from their combination.
How this product is rated for Heart Health
Ingredient fit80
EPA and DHA provide the main recognized connection. EPA and DHA provide partial exposure coverage in the saved comparison, without establishing a proven effective dose.
Goal fit
EPA and DHA are the main recognized focus.
Dose adequacy
EPA and DHA provide partial exposure coverage in the saved comparison, without establishing a proven effective dose.
Pathways58
The findings center on triglyceride handling, with narrow coverage across the evaluated functions.
Depth
The main recognized connection is triglyceride handling.
Breadth
The breadth finding centers on triglyceride handling, rather than broad coverage of different heart-health functions.
Evidence100
EPA supplies the strongest evidence finding here, chiefly for triglyceride support rather than routine event prevention.
Evidence strength
EPA supplies the strongest evidence finding here, chiefly for triglyceride support rather than routine event prevention.
Studied preparation
The saved preparation check recognizes the counted declarations; this does not establish product-specific trial results.
Formulation logic100
EPA and DHA have no identified required-partner gap or configured conflict. All ingredients counted for this check meet its minimum exposure criterion; that criterion is not proof of clinical benefit.
Partner coverage
No missing required partner was identified among the counted ingredients; this does not establish added benefit from combining them.
Conflicts
No configured ingredient conflict was identified in the supplied facts.
Effective doses
All ingredients counted for this check meet its minimum exposure criterion; that criterion is not proof of clinical benefit.
Impact
Moderate effect
Fish Oil · 1250 mg
EPA and DHA are marine omega-3 fats that may lower blood markers of inflammation. They act through fatty-acid messengers involved in inflammatory responses. Changes in those markers do not guarantee less pain or a noticeable improvement in everyday health, and a larger amount does not automatically mean a greater benefit.
How this product is rated for Inflammation
Ingredient fit69
The relevant ingredients provide connections to inflammation. The amount and relevant form affect how closely the serving matches that role.
Goal fit
Several ingredients have inflammation-related roles; other actives serve different purposes.
Dose adequacy
The serving declares 750 mg EPA and 250 mg DHA separately; generic fish-oil mass cannot replace the declared active amounts.
Pathways15
The ingredients relate to fatty-acid messengers involved in inflammation. This describes their possible roles, rather than a guarantee of symptom relief.
Depth
The ingredients relate to fatty-acid messengers involved in inflammation. This describes their possible roles, rather than a guarantee of symptom relief.
Breadth
The relevant ingredients concentrate on one type of inflammatory process rather than several distinct mechanisms.
Evidence70
EPA and DHA may lower inflammatory blood markers; this does not guarantee symptom relief.
Evidence strength
EPA and DHA may lower inflammatory blood markers; this does not guarantee symptom relief.
Studied preparation
The declared ingredients have relevant preparation details, but a matching form alone does not guarantee inflammation relief.
Formulation logic100
No particular ingredient conflict is identified. The individual roles do not imply an added benefit from combining them.
Partner coverage
The relevant ingredients do not require an additional partner for their individual roles.
Conflicts
No particular ingredient conflict is identified in the available facts.
Effective doses
The ingredient amounts differ substantially; small amounts should not be assumed to add meaningful inflammation relief.
Impact
High effect
Fish Oil · 1250 mg
EPA and DHA provide the relevant connection to triglyceride metabolism, with 750 mg EPA and 250 mg DHA separately declared per serving. These amounts receive partial exposure-based recognition, without treating the unresolved fish-oil row as another combined active declaration. The higher purified-component trial exposures and selected study populations limit transfer of the findings, and cardiovascular-event prevention is not established.
How this product is rated for Cardiovascular Support
Ingredient fit78
The recognized ingredients give the formula a focused cardiovascular connection, without establishing a clinical effect. Explicit EPA and DHA amounts contribute separately; an unresolved oil declaration is not converted to combined active content.
Goal fit
The recognized ingredients give the formula a focused cardiovascular connection, without establishing a clinical effect.
Dose adequacy
Explicit EPA and DHA amounts contribute separately; an unresolved oil declaration is not converted to combined active content.
Pathways60
The saved support centers on triglyceride metabolism, without establishing cardiovascular-event prevention.
Depth
The saved support centers on triglyceride metabolism, without establishing cardiovascular-event prevention.
Breadth
Only the leading area meets the saved coverage criterion, leaving support narrow across the assessed cardiovascular areas.
Evidence83
EPA leads the recognized evidence for triglyceride-related measures, without establishing routine event prevention.
Evidence strength
EPA leads the recognized evidence for triglyceride-related measures, without establishing routine event prevention.
Studied preparation
The saved result recognizes the preparations retained for this check; that recognition does not expand their demonstrated clinical benefits.
Formulation logic100
No required partner is missing and no configured conflict was matched. All ingredients retained for this check meet its minimum amount criterion; this does not establish effective clinical dosing.
Partner coverage
The recognized ingredients can contribute alone or have their required partner; no missing-partner limitation was found.
Conflicts
No configured conflict was matched in the supplied facts; this does not establish general safety.
Effective doses
All ingredients retained for this check meet its minimum amount criterion; this does not establish effective clinical dosing.
Impact
High effect
DHA contributes to brain-cell membranes, but its supplied cognitive evidence concerns months of use in adults with low DHA intake, chiefly for memory and reaction time. EPA research also concerns repeated intake and varied populations. These roles do not establish an immediate improvement in everyday concentration.
How this product is rated for Mental Focus
Ingredient fit64
DHA (Docosahexaenoic Acid), EPA (Eicosapentaenoic Acid) underpin this product’s connection to focus. Some amounts provide only a partial match to the saved comparison ranges.
Goal fit
The formula includes ingredients aimed at other purposes, so its focus connection is less concentrated.
Dose adequacy
The included amounts only partly meet the saved reference ranges for the relevant ingredients.
Pathways54
The main mapped contribution is synaptic plasticity and neuroprotection. The mechanism alone does not establish an acute focus benefit.
Depth
Synaptic plasticity and neuroprotection is the strongest mapped route, with partial coverage. That biological connection does not itself demonstrate acute focus improvement.
Breadth
The meaningful mapped contribution is concentrated in one route, with limited breadth across other aspects of focus.
Evidence56
The supplied evidence is limited for immediate everyday focus, despite the biological roles reflected in the saved findings.
Evidence strength
The leading ingredient supplies the evidence finding, but the supplied science does not establish routine acute focus enhancement.
Studied preparation
Preparation matching is incomplete for DHA.
Formulation logic100
The included ingredients have no identified configured conflict. No required partner is missing.
Partner coverage
No required partner is missing for the included ingredients.
Conflicts
No configured ingredient conflict was identified in the supplied findings.
Effective doses
The included ingredients meet the saved minimum amount threshold; that threshold is not a demonstrated effective dose for acute focus.
DHA (Docosahexaenoic Acid) Not classified
No linked studies yet.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Calories | 11 {Calories} | |
Calories from Fat | 11 {Calories} | |
Total Fat | 1.2 Gram(s) | |
Saturated Fat | 0 Gram(s) | |
Polyunsaturated Fat | 1.1 Gram(s) | |
Trans Fat | 0 Gram(s) | |
Cholesterol | 0 mg | |
concentrated Fish Oil | 1250 mg | |
Eicosapentaenoic Acid | 750 mg | |
Docosahexaenoic Acid | 250 mg | |
Other Omega-3 Fatty Acids | 60 mg |
Omega-3 · 60 mg OverallScore77
A serving lists 750 mg EPA and 250 mg DHA in ethyl ester form. The saved facts also record a qualifying product certification claim.
How this ingredient is rated
Active Ingredient Quality & Bioavailability42
The omega-3s are identified as ethyl esters. An antioxidant is recorded, but the available source evidence does not meet the evaluation’s more specific criteria.
Molecular Form & Absorption Potential
The omega-3s are identified as ethyl esters, a form the evaluation favors less than triglycerides.
Source Purity & Oxidative Protection
An antioxidant is recorded, but the available source evidence does not meet the evaluation’s more specific criteria.
Dose, Safety & Label Transparency100
A serving lists 750 mg EPA and 250 mg DHA. Together these account for about 80% of the stated oil.
EPA & DHA Label Specificity
A serving lists 750 mg EPA and 250 mg DHA separately.
Active Ingredient Concentration
EPA and DHA together make up about 80% of the stated 1,250 mg of oil per serving.
Third-Party Purity Verification
The saved facts record a qualifying product certification claim; the certification has not been independently verified here.
Value100
The price works out to about $0.59 per 1,000 mg of EPA and DHA combined.
Price per 1000mg of EPA+DHA
The price works out to about $0.59 per 1,000 mg of EPA and DHA combined.
EPA (Eicosapentaenoic Acid) · 750 mg OverallScore74
A serving provides 750 mg of EPA in ethyl ester form and 250 mg of DHA. Its EPA costs about $0.79 per gram.
How this ingredient is rated
Active Ingredient Quality & Bioavailability55
The oil uses an ethyl ester form. EPA is only part of the stated fish oil amount.
Molecular Form and Bioavailability
The omega-3 oil is identified as ethyl esters, a different molecular form from triglycerides.
EPA Concentration Density
EPA makes up about 60% of the stated fish oil amount per serving.
Oxidation Protection
Tocopherols are included; their presence does not measure the oil’s freshness.
Dose, Safety & Label Transparency90
The serving provides 750 mg EPA and 250 mg DHA.
Absolute EPA Dose per Serving
Each serving provides 750 mg of EPA.
EPA-Centric Ratio
The serving has 750 mg of EPA and 250 mg of DHA, so it contains more EPA than DHA.
Purity and Contaminant Testing
The saved evaluation records a qualifying contaminant-testing or certification claim; the claim has not been independently verified.
Value80
At about $0.79 per gram of EPA, the EPA cost is relatively low in this comparison.
Price per Gram of EPA
The estimate uses the stated EPA amount and price per whole-product serving.
Fish Oil · 1250 mg OverallScore82
Each serving provides 1,000 mg of EPA and DHA combined from 1,250 mg of fish oil. The saved facts identify the oil as ethyl ester form.
How this ingredient is rated
Active Ingredient Quality & Bioavailability72
The saved facts identify the oil as ethyl ester form. A specific purification method and third-party certification are recorded as claims.
Omega-3 Molecular Form
The saved facts identify the oil as ethyl ester form.
Purification & Filtration Method
The saved assessment records a specific purification-method claim; that claim is not independent proof of contaminant removal.
Third-Party Purity & Potency Verification
The saved assessment records a recognized third-party certification claim; the program is not identified in the available facts.
Source & Sustainability
A sustainability certification claim is recorded; the saved facts do not establish a qualifying named source.
Dose, Safety & Label Transparency94
Each serving has 1,000 mg EPA and DHA, about 80% of the stated fish oil. The saved facts record a qualifying antioxidant.
Total Active Omega-3 Dose (EPA + DHA)
Each serving supplies 1,000 mg of EPA and DHA combined, a larger amount in this assessment.
Omega-3 Potency & Concentration
The 1,000 mg of EPA and DHA represent about 80% of the 1,250 mg fish oil per serving.
EPA & DHA Individual Disclosure
EPA and DHA are separately stated as 750 mg and 250 mg per serving, respectively.
Oxidation Protection (Stabilizers)
A qualifying antioxidant is recorded in the saved facts; its presence does not establish measured freshness.
Value80
The whole-product serving price corresponds to about $0.59 per gram of EPA and DHA, a moderate cost in this comparison.
Cost Per Gram of Active EPA + DHA
The whole-product serving price corresponds to about $0.59 per gram of EPA and DHA, a moderate cost in this comparison.
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Marine Omega-3 Supplementation and Cardiovascular Disease: An Updated Meta-Analysis of 13 Randomized Controlled Trials Involving 127 477 Participants.
- Impact of omega-3 fatty acids on hypertriglyceridemia, lipidomics, and gut microbiome in patients with type 2 diabetes.
- A systematic review of fish-oil supplements for the prevention and treatment of hypertension.
- Effects of fish oil-derived fatty acids on suboptimal cardiovascular health: A multicenter, randomized, double-blind, placebo-controlled trial.
- Effect of High-Dose Marine Omega-3 Fatty Acids on Atherosclerosis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
- Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis.
- Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS).
- Effects of omega-3 fatty acids on coronary revascularization and cardiovascular events: a meta-analysis.
- Incremental effects of eicosapentaenoic acid on cardiovascular events in statin-treated patients with coronary artery disease.
- Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association.
- Dose-dependent effects of fish oil on cardio-metabolic biomarkers in healthy middle-aged and elderly Chinese people: a double-blind randomized controlled trial.
- Eicosapentaenoic acid supplementation alleviates pruritus, enhances skin moisture, and mitigates depression in maintenance hemodialysis patients.
- Lowering effects of fish oil supplementation on proinflammatory markers in hypertension: results from a randomized controlled trial.
- The effects of ω-3 fish oil emulsion-based parenteral nutrition plus combination treatment for acute paraquat poisoning.
- Effects of Omega-3 Fatty Acid Intake in Patients Undergoing Dialysis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- The influence of n-3 polyunsaturated fatty acids on cognitive function in individuals without dementia: a systematic review and dose-response meta-analysis.
- EPA supplementation improves teacher-rated behaviour and oppositional symptoms in children with ADHD.
- Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA)-Should They Be Mandatory Supplements in Pregnancy?
- Supplementation with oil rich in eicosapentaenoic acid, but not in docosahexaenoic acid, improves global cognitive function in healthy, young adults: results from randomized controlled trials.